RDT announces 510(k) FDA Clearance for Tempus Technology

Release date 23rd January 2018

Remote Diagnostic Technologies (RDT) are pleased to announce that we have received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the integrated printer configuration of the Tempus Pro. This configuration of Tempus Pro enables a user to print medical records such as ECG strips on-demand.

Tempus Pro is rapidly becoming the monitor of choice for many NATO militaries around the globe. This configuration of the device is another example of RDT’s progress and commitment to continuously innovate and offer best-in-class technology for prehospital care.

RDT’s success story is set to continue. In the past 4 years, the business has trebled in size. In the past 2 years, it has doubled. Revenue is up 60% in the past year. Business is set to double again in the next 2 years.

About Remote Diagnostic Technologies Ltd:

RDT is a fast growing and customer focused, high-technology medical device business. We specialise in the design, manufacture, sales, marketing and worldwide distribution of best-in-class monitoring and resuscitation solutions. RDT are acutely focused on the prehospital market and continuously innovate to evolve our technologies, offering our customers unparalleled capabilities. Data & communications is core to all we do. With success success on a global scale, we serve an International customer base – driven and supported by a team of ~100. Founded in 1997, RDT is based in Basingstoke, Hampshire.